For a quarter of a century, gene therapy has been stymied, largely because the patient’s immune system attacks the treatment as a suspected rogue – or because it actually does turn rogue.Now, University of Pennsylvania researchers have convincingly shown that they can overcome these formidable obstacles. Cells that were genetically modified to fight HIV have persisted for up to 11 years – and counting – without bad side effects in 41 patients.
View the original article here: Penn researchers report a gene-therapy success – Philadelphia Inquirer
